Prokaryotic Expression and Polyclonal Antibody Preparation of PRL3

Phosphatase of regenerating liver 3(PRL3),which belongs to the superfamily of protein tyrosine phosphatases(PTPs),represents a group of low molecular weight PTPs that participate in tumorigenesis and metastasis processes.Presented here are the results of cloning,prokaryotic expression,purification,and polyclonal antibody preparation of PRL3.To obtain a specific polyclonal antibody against PRL3,the authors have prepared GST-PRL3 to immunize rabbits and purify an anti-PRL3 polyclonal antibody by negative selection affinity columns.Western blot analysis shows that the anti-PRL3 polyclonal antibody has a specific binding ability with PRL3 protein.The anti-PRL3 polyclonal antibody provides a good tool to further study the function of PRL3.     

功能微粒材料的制备及其细胞作用研究(英文)

随着纳米科学的迅速发展,越来越多的微粒材料被设计和制备出来,并应用于生物医学领域,取得了令人瞩目的进展和成就。近年来,我们课题组发展了一系列具备可控表面化学与结构、特定刺激响应性能和可控装载与释放性能的微粒材料,尤其是基于层层自组装的中空微胶囊。同时,我们也致力于研究微粒材料与细胞的相互作用,阐明其物理化学性质对细胞内吞和细胞功能的影响。通过这些研究,我们希望进一步建立功能性微粒材料的生物学功能优化的规律,推动其在生物医学领域的应用。     

Structure-Activity Relationship, Cytotoxicity and Mode of Action of 2-Ester-substituted 1,5-Benzothiazepines as Potent Antifungal Agents

Our studies examined the structural features responsible for the antifungal activity of 2-ethoxycarbonyl-1,5- benzothiazepine （7a）. Three series of 1,5-benzothiazepine derivatives were synthesized and screened for their antifungal activity. The results suggested that the ethoxycarbonyl group at the 2 position and the imine moiety on the seven-membered ring are essential for activity. The most potent of the synthesized analogues （7a, 7b） were further studied by evaluating their cytotoxicity and mode of action （for 7a）. The results showed that compounds 7a and 7b were relatively safe for BV2 cells, but compound 7a interfered with Cryptococcus neoformans cell wall integrity by increasing the chitinase activity. Therefore, compound 7a was considered safe as an antifungal agent for animal cells.     

新型苯并[b]氮杂?-查尔酮杂合物的设计、合成及抗肿瘤活性研究

为了寻找高效、低毒的抗肿瘤药物，基于分子杂交的策略，将苯并[b]氮杂?结构引入查尔酮母体结构中，设计了12个未见文献报道的苯并[b]氮杂?-查尔酮杂合物（7a~7l）。并以苯胺为原料，经N-烷基化、羰基化、水解、环化和Claisen-Schmidt缩合反应合成了7a~7l，其结构经¹HNMR, ¹³CNMR和HR-MS(ESI)表征。采用MTT法评估了目标化合物对人胃癌细胞（HGC-27）、人肝癌细胞（HepG2）、人非小细胞肺癌细胞（A549）和人正常胃粘膜上皮细胞（GES-1）的抗增殖活性，并进一步采用流式细胞术和蛋白印迹法实验在细胞和蛋白水平上探究了活性最优化合物的抗肿瘤机制。结果表明：目标化合物对HGC-27细胞表现出较高的抗增殖活性，其中化合物7d对HGC-27细胞的抗增殖活性最强(IC₅₀=0.78 μmol•L^-1)，优于阳性对照顺铂(IC₅₀=7.38 μmol•L^-1)，同时其对人正常细胞GES-1的毒性较低（IC₅₀=22.77 μmol•L^-1, SI=29.19），弱于阳性对照顺铂（IC₅₀=9.51 μmol•L^-1, SI=1.29）。抗肿瘤机制研究表明:化合物7d能够将癌细胞HGC-27的细胞周期阻滞在G2/M期，并通过增加促凋亡蛋白Bax和降低抗凋亡蛋白Bcl-2的表达来诱导HGC-27细胞的凋亡。      

β-环糊精聚轮烷的合成及其细胞摄取行为的研究

以聚丙二醇-双[3,4,5-三(炔丙氧基)苯甲酰胺]为轴,以小体积的2-叠氮乙醇为封端剂通过水相炔-叠氮点击化学反应(Cu AAC)生成的多个三氮唑进行封端,合成了新型的β-环糊精聚轮烷.利用核磁氢谱和旋转坐标系欧沃豪斯增益谱对所合成的β-环糊精聚轮烷进行了结构表征.进一步通过聚轮烷上的羟基,在聚轮烷上依次共价连接了水溶性聚合物聚乙二醇和荧光分子FITC,对聚轮烷进行了亲水化改性和荧光标记,研究了改性后的聚轮烷的细胞毒性和细胞摄取行为,结果表明,改性后的聚轮烷具有良好的细胞相容性,并可通过胞吞的方式被细胞摄取.     

含酯键的可降解聚合物基因载体研究进展

基因治疗作为一种极富潜力、用于替代传统化学治疗的方法,为先天性遗传疾病和严重后天获得性疾病的治疗提供了一条富有前景的新途径。有效释放是基因高效表达的关键,将降解基团引入基因载体可有效地提高基因释放效率,且降解后的小片段更易代谢排出体外,从而有效降低细胞毒性。本文依据材料结构及制备方法对新型聚酯材料进行分类,从转染效率、细胞毒性以及降解性能方面综述了可降解聚酯类基因载体的最新研究进展,并对发展前景进行了展望。     

急性髓细胞白血病基因筛选模型的贝叶斯分析

基因表达数据蕴含着大量的生物信息,在生物基因信息研究中,筛选表达水平发生显著变化的差异基因是认识疾病形成机理和辅助靶点药物研究的关键问题.根据急性髓细胞白血病(AML)的基因表达数据,构造基因均值差序列,建立贝叶斯分层混合模型,并为模型的参数赋予具有基因生物特征的先验信息.采用马尔可夫链蒙特卡洛(MCMC)算法对模型参数进行估计,并筛选出急性髓细胞白血病差异表达基因.在实际数据分析中,从美国生物信息中心(NCBI)的高通量基因表达数据库中获取急性髓细胞白血病基因数据集,从经过非特异滤波预处理的14688个急性髓细胞白血病基因中筛选出711个差异表达基因,差异表达基因数仅占急性髓细胞白血病基因总数的4.84%,这一结果与基因差异表达的生物学原理相吻合.     

一类具Rotenberg模型解的存在性

迁移方程是研究物质中的粒子运动所产生的微观效应综合所致的宏观迁移现象规律的一种模型,研究这类迁移方程对数学基础理论的发展有着非常重要的意义.在L_1空间中,运用线性算子理论,研究了种群细胞增生中具Rotenberg模型的迁移方程,采用所谓的豫解算子等法证明了种群细胞增生中具Rotenberg模型解的存在性.     

Design and Synthesis of Tri-substituted Chiral Pyrrolidin-2-one Derivatives as CCR4 Antagonists

A series of tri-substituted chiral pyrrolidin-2-one derivatives have been designed and synthesized as CC chemokine receptor 4 （CCR4） antagonists. The structure of CCR4 was built by homology modeling. Asymmetric synthesis was applied to synthesize the R,R configuration chiral pyrrolidin-2-one scaffold. The stereoisomeric con- figurations of the compounds were identified by 2D I H-~H COSY spectroscopy and 1D NOESY spectroscopy. This method was more economical and convenient than traditional X-ray single crystal diffraction. In addition, the inter- actions between these compounds and the N-terminal extracellular tail of CCR4 were studied using capillary zone electrophoresis. The CCR4 chemotaxis inhibition effect was tested in CCR4-transfected HEK293 cells. Several compounds showed potent activities as CCR4 antagonists. Among these compounds, lc is the most active one. Its apparent binding constant of CZE experiment result is （1.569±0.11）× 10s L·mol ^-1, and its percentage inhibition of the HEK293/CCR4 cells migration with the concentration of I gmol·L ^-1 in DMSO is 59%. And compound If has slightly higher affinity to N-terminal of CCR4 according to its apparent binding constant than lb because of the in- troduced ester linkage. Further studies on the mechanism of these compounds are in progress.